Mark Meury has an impressive professional background, having served as the Executive Vice President and Chief Commercial Officer at Seattle Genetics for nearly a decade. With his extensive experience in the biotechnology industry, Meury has a deep understanding of global pharmaceutical and biotech markets, as well as expertise in strategic planning and commercial operations. Throughout his career, he has successfully led pharmaceutical launches and business development initiatives, driving significant revenue growth for his companies.

Prior to his time at Seattle Genetics, Meury held various leadership positions at Bristol-Myers Squibb, including Head of U.S. Oncology Sales and Marketing. He has also held positions at GlaxoSmithKline and Bausch & Lomb. Mark Meury received his bachelor's degree in business from Furman University and an MBA from the University of Pittsburgh.

As an industry leader with a diverse skill set and a wealth of experience, Mark Meury is a sought-after speaker and has been featured in publications such as Forbes and FiercePharma. He is passionate about improving patient outcomes through the development of innovative therapies and the expansion of access to healthcare.